Skip to main content
Clinical Trials/JPRN-UMIN000049620
JPRN-UMIN000049620
Not yet recruiting
未知

Explore of Minimal clinically important differences (MCID) of the Scale for the Assessment and Rating of Ataxia (SARA) and the Vertigo Symptom Scale- short form (VSS-sf) in stroke. A multicenter prospective observational study. - Explore of Minimal clinically important differences (MCID) of the Scale for the Assessment and Rating of Ataxia (SARA) and the Vertigo Symptom Scale- short form (VSS-sf) in stroke. A multicenter prospective observational study.

Sakurakai Hospital0 sites120 target enrollmentDecember 1, 2022
ConditionsStroke

Overview

Phase
未知
Intervention
Not specified
Conditions
Stroke
Sponsor
Sakurakai Hospital
Enrollment
120
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2022
End Date
March 31, 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Sakurakai Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) before this stroke, modified Rankin Scale : mRS\=\>2 (2\) Mini Mental State Examination\-J (MMSE\-J) \<\= 23 (3\) dropout from rehabilitation program

Outcomes

Primary Outcomes

Not specified

Similar Trials